Zhejiang Anglikang Pharmaceutical Co. Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -1.53% vs -14.50% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -8.95% vs -45.78% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "340.20",
          "val2": "345.50",
          "chgp": "-1.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.30",
          "val2": "39.00",
          "chgp": "-32.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "3.30",
          "chgp": "-9.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "23.40",
          "val2": "25.70",
          "chgp": "-8.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "77.40%",
          "val2": "56.20%",
          "chgp": "2.12%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -7.10% vs -5.30% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.16% vs -17.04% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,415.30",
          "val2": "1,523.40",
          "chgp": "-7.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "227.70",
          "val2": "204.10",
          "chgp": "11.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.60",
          "val2": "17.10",
          "chgp": "-20.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.20",
          "val2": "-1.80",
          "chgp": "111.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "156.70",
          "val2": "151.90",
          "chgp": "3.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "105.80%",
          "val2": "75.90%",
          "chgp": "2.99%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

340.20

345.50

-1.53%

Operating Profit (PBDIT) excl Other Income

26.30

39.00

-32.56%

Interest

3.00

3.30

-9.09%

Exceptional Items

0.30

0.00

Consolidate Net Profit

23.40

25.70

-8.95%

Operating Profit Margin (Excl OI)

77.40%

56.20%

2.12%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -1.53% vs -14.50% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -8.95% vs -45.78% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,415.30

1,523.40

-7.10%

Operating Profit (PBDIT) excl Other Income

227.70

204.10

11.56%

Interest

13.60

17.10

-20.47%

Exceptional Items

0.20

-1.80

111.11%

Consolidate Net Profit

156.70

151.90

3.16%

Operating Profit Margin (Excl OI)

105.80%

75.90%

2.99%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -7.10% vs -5.30% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 3.16% vs -17.04% in Dec 2024

All Annual Results